Trilostane in Dogs
Generic: Trilostane
Trilostane is a prescription oral medication primarily used to manage hyperadrenocorticism, commonly known as Cushing's disease, in dogs by regulating excessive cortisol production.
This medication is intended for dogs.
Overview
Trilostane is a synthetic steroid analogue that serves as a cornerstone therapy for dogs diagnosed with pituitary-dependent or adrenal-dependent hyperadrenocorticism. Unlike older treatments like Mitotane, which works by causing selective necrosis of the adrenal cortex, Trilostane acts as a reversible inhibitor, providing a more controlled management strategy for elevated cortisol levels. Because the condition is chronic, most dogs will require lifelong treatment, necessitating regular monitoring to ensure their endocrine system remains within a stable, healthy range. Without proper management, the excess cortisol can lead to severe systemic health issues, including muscle wasting, skin disease, and increased vulnerability to infections.
The initiation of Trilostane therapy is a significant clinical milestone that requires a close partnership between the pet owner and the veterinarian. Clinical signs of Cushing's syndrome—such as increased thirst, excessive urination, and a pot-bellied appearance—often begin to subside within a few weeks of starting treatment. However, because each dog responds uniquely to the medication, serial blood testing, specifically ACTH stimulation tests, is essential to determine the correct dose. This careful titration ensures that the dog does not accidentally develop Addison's disease, a condition where cortisol levels drop too low, which can be life-threatening.
Management of endocrine disorders in veterinary medicine is complex, as many patients may require additional therapies for concurrent issues. For instance, some dogs with Cushing's syndrome may also suffer from diabetes mellitus and require Insulin (Caninsulin/Vetsulin) to manage blood glucose levels, which can complicate the overall treatment picture. Other patients might require thyroid support if they also suffer from hypothyroidism, often necessitating the use of Levothyroxine. Managing these interrelated conditions requires meticulous observation by owners to note any changes in behavior, appetite, or energy levels, as even subtle shifts can indicate that the medication needs adjustment.
While Trilostane is highly effective for the majority of canine patients, it is not a cure and requires long-term commitment. Owners should be aware that regular follow-up visits are non-negotiable, as the dosage needs of a pet can shift over time. By maintaining strict adherence to the prescribed administration schedule and attending all diagnostic check-ups, pet owners can significantly improve their dog's quality of life and longevity. Should complications arise or if there are concerns regarding efficacy, clinicians may consider alternative protocols or evaluate the patient for secondary complications associated with prolonged hyperadrenocorticism.
What It Treats
- Pituitary-Dependent Hyperadrenocorticism (PDH): The most common form of Cushing's disease caused by a pituitary tumor stimulating excessive cortisol production.
- Adrenal-Dependent Hyperadrenocorticism (ADH): A form of Cushing's disease where an adrenal tumor produces excess cortisol.
- Alopecia X: Occasionally used off-label to manage hair loss in certain breeds that present with symptoms similar to Cushing's but lack other systemic markers.
How It Works
Trilostane functions as a competitive inhibitor of the enzyme 3-beta-hydroxysteroid dehydrogenase. This enzyme is crucial in the biosynthetic pathway that converts pregnenolone into progesterone and 17-hydroxypregnenolone into 17-hydroxyprogesterone. By blocking this specific pathway, the medication effectively shuts down the production of cortisol in the adrenal glands. Because this action is reversible, the drug's effect lasts for a limited time, allowing for a safer, titratable reduction of excess glucocorticoid hormones in the bloodstream. Unlike therapies that permanently destroy adrenal tissue, Trilostane lowers circulating cortisol concentrations without depleting the adrenal cortex entirely. This mechanism allows the body to maintain basic functions while correcting the hyper-metabolic state induced by the disease. Regular monitoring is required because the degree of inhibition varies between individual dogs, and the goal is to reach a therapeutic range that controls symptoms while avoiding an iatrogenic 'crash' into hypoadrenocorticism.
Dosage
Dosage is highly individualized based on the dog's body weight, the results of an ACTH stimulation test, and clinical symptoms. Owners must follow the exact milligram strength and frequency prescribed by their veterinarian, as under-dosing will fail to control the disease, while over-dosing can lead to life-threatening adrenal failure. Never adjust the dose or skip a scheduled administration without explicit authorization from the attending veterinarian.
Administration
Trilostane is typically administered orally once or twice daily, depending on the veterinarian's specific protocol. For optimal absorption, it is generally recommended to give the medication with food, as this helps to stabilize the drug's effect and potentially reduces the risk of gastrointestinal upset. Always use the specific capsule size prescribed, and do not open, crush, or divide capsules, as this can lead to incorrect dosing or exposure to the active compound.
Storage
Store the medication in a tightly closed, child-proof container at room temperature (typically between 59°F and 77°F). It is important to keep the capsules away from moisture, heat, and direct sunlight, as these factors can degrade the stability and effectiveness of the medication. Ensure the bottle is kept out of reach of pets and children at all times.
Contraindications
Trilostane is contraindicated in dogs with primary hepatic or renal disease, as the liver is the primary site of drug metabolism and the kidneys assist in excretion. The use of this medication in patients with pre-existing electrolyte imbalances or dehydration is also generally discouraged until these values have stabilized, as treatment could exacerbate these issues. Furthermore, Trilostane should not be used in pregnant dogs or breeding animals, as the suppression of hormones can interfere with normal reproductive cycles and fetal development. Owners should also avoid using this medication if the dog has a known hypersensitivity to the drug or any of its inactive ingredients.
Interactions
Known drug interactions primarily involve medications that may further suppress adrenal function or impact blood pressure. Concomitant use with ACE inhibitors (such as enalapril or benazepril) should be approached with caution, as this can increase the risk of hyperkalemia (high blood potassium levels). Careful monitoring of electrolytes is mandatory when these drugs are combined. Additionally, owners should inform their veterinarian if the pet is taking potassium-sparing diuretics or any other systemic corticosteroids. Because these substances affect the same endocrine pathways, the combination can lead to unpredictable blood cortisol and electrolyte levels, necessitating more frequent blood monitoring to avoid medical emergencies.
Side Effects
- Lethargy
- Decreased appetite or anorexia
- Vomiting
- Diarrhea
- Weakness or collapse
- Addisonian crisis (severe electrolyte imbalance, dehydration, shock)
- Adrenal gland necrosis (rare)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.